Bioenvision (MM) News - BIVN

FeaturedNorth Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton

Bioenvision to Host First Quarter 2006 Financial Results Conference Call

Bioenvision (NASDAQ NM: BIVN) today announced that the Company will host a conference call with the financial community to discuss the first...

Clofarabine's Duration of Response Improves Outcome for Elderly AML Patients

Bioenvision (Nasdaq:BIVN) today announced significant duration of response data were presented at recent scientific meetings for clofarabine in...

Bioenvision to Present at CIBC World Markets Sixteenth Annual Healthcare Conference

Bioenvision, Inc. (Nasdaq:BIVN) announced today that Dr. Christopher B. Wood, Chairman and Chief Executive Officer of the Company, will present at...

Bioenvision Reports 2005 Year-End Financial Results

Bioenvision (NASDAQ NM:BIVN) announced financial results for the fiscal year ended June 30, 2005. Highlights of the year and the fourth quarter...

Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C; Phase II Results to be Presented at UBS Global Life Science

Bioenvision (Nasdaq NM:BIVN) today announced interim results from the ongoing investigator sponsored Phase II clinical study of BIVN-401...

Bioenvision Reschedules Year-End Financial Results Conference Call

Bioenvision (NASDAQ NM: BIVN) today announced that it has rescheduled its year-end earnings call that was originally scheduled for September 27 at...

Bioenvision to Hold Fiscal 2005 Year-End Financial Results Conference Call Tuesday, September 27, 2005

Bioenvision (NASDAQ NM: BIVN) will release fiscal 2005 year-end financial results before the market opens on Tuesday, September 27, 2005. ?...

First Patients Enrolled in Phase II and Phase IV Breast Cancer Studies for Bioenvision's Modrenal(R)

Bioenvision (Nasdaq NM: BIVN) today announced that the first seven patients had been enrolled in a Phase IV clinical study of Modrenal(R...

Bioenvision to Present at UBS Global Life Sciences Conference

Bioenvision (NASDAQ:BIVN) announced today that it will participate in the 2005 UBS Global Life Sciences Conference scheduled for September 26-29...

Bioenvision Reports Third Quarter Fiscal 2005 Financial Results

Bioenvision (NASDAQ:BIVN) today announced financial results for the three and nine months ended March 31, 2005. Highlights of the quarter and...

Bioenvision Receives Notification from Nasdaq Regarding Removal of ''E'' from Trading Symbol

Bioenvision, Inc. (Nasdaq: BIVN) today announced that the Nasdaq Listings Qualifications Panel has approved its request for continued listing on...

Clofarabine Active in a Broad Range of Hematologic Cancers; Data Presented at 10th European Haematology Association -EHA- Sympos

Bioenvision (Nasdaq: BIVN) announced that clofarabine's potential as the next generation of leukemia treatment was a focal point during a...

Bioenvision to Hold Fiscal 2005 Third Quarter Financial Results Conference Call Monday, May 16, 2005

Bioenvision (NASDAQ:BIVN) will release fiscal 2005 third quarter financial results before the market opens on Monday, May 16, 2005. ? Christopher...

SAP Business One and CompuData Selected by Bioenvision

SAP Business One and CompuData Selected by Bioenvision PHILADELPHIA, March 15 /PRNewswire/ -- CompuData, an SAP Business Partner, today...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bioenvision (MM) (BIVN)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

BIVN News

FeaturedNorth Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton

Bioenvision to Host First Quarter 2006 Financial Results Conference Call

Clofarabine's Duration of Response Improves Outcome for Elderly AML Patients

Bioenvision to Present at CIBC World Markets Sixteenth Annual Healthcare Conference

Bioenvision Reports 2005 Year-End Financial Results

Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C; Phase II Results to be Presented at UBS Global Life Science

Bioenvision Reschedules Year-End Financial Results Conference Call

Bioenvision to Hold Fiscal 2005 Year-End Financial Results Conference Call Tuesday, September 27, 2005

First Patients Enrolled in Phase II and Phase IV Breast Cancer Studies for Bioenvision's Modrenal(R)

Bioenvision to Present at UBS Global Life Sciences Conference

Bioenvision Reports Third Quarter Fiscal 2005 Financial Results

Bioenvision Receives Notification from Nasdaq Regarding Removal of ''E'' from Trading Symbol

Clofarabine Active in a Broad Range of Hematologic Cancers; Data Presented at 10th European Haematology Association -EHA- Sympos

Bioenvision to Hold Fiscal 2005 Third Quarter Financial Results Conference Call Monday, May 16, 2005

SAP Business One and CompuData Selected by Bioenvision

BIVN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bioenvision (MM) (BIVN) News

Bioenvision (MM) (BIVN)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

BIVN News

FeaturedNorth Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton

Bioenvision to Host First Quarter 2006 Financial Results Conference Call

Clofarabine's Duration of Response Improves Outcome for Elderly AML Patients

Bioenvision to Present at CIBC World Markets Sixteenth Annual Healthcare Conference

Bioenvision Reports 2005 Year-End Financial Results

Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C; Phase II Results to be Presented at UBS Global Life Science

Bioenvision Reschedules Year-End Financial Results Conference Call

Bioenvision to Hold Fiscal 2005 Year-End Financial Results Conference Call Tuesday, September 27, 2005

First Patients Enrolled in Phase II and Phase IV Breast Cancer Studies for Bioenvision's Modrenal(R)

Bioenvision to Present at UBS Global Life Sciences Conference

Bioenvision Reports Third Quarter Fiscal 2005 Financial Results

Bioenvision Receives Notification from Nasdaq Regarding Removal of ''E'' from Trading Symbol

Clofarabine Active in a Broad Range of Hematologic Cancers; Data Presented at 10th European Haematology Association -EHA- Sympos

Bioenvision to Hold Fiscal 2005 Third Quarter Financial Results Conference Call Monday, May 16, 2005

SAP Business One and CompuData Selected by Bioenvision

BIVN Discussion

Your Recent History